Phase 2 human clinical trial shows that metabolic activators improve cognitive function in Parkinson’s disease patients
ScandiBio Therapeutics announced Phase 2 clinical trial results from the study on the open-access server medRxiv.org. The results: Combined Metabolic Activators Improve Cognitive Functions without Altering…